ZOMIG

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug ZOMIG contains one active pharmaceutical ingredient (API):

1 Zolmitriptan UNII 2FS66TH3YW - ZOLMITRIPTAN

Zolmitriptan has been demonstrated to be a selective agonist for the vascular human recombinant 5HT1B and 5HT1D receptor subtypes. Zolmitriptan is a high affinity 5HT1B/1D receptor agonist with modest affinity for 5HT1A receptors. Read about Zolmitriptan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZOMIG Nasal spray	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
ZOMIG Film-coated tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02CC03	Zolmitriptan	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8266C
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 542818090002117, 542818090002217
Country: CA	Health Products and Food Branch	Identifier(s): 02238660, 02243045, 02248992, 02248993
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00784674, 02759982, 09279156
Country: EE	Ravimiamet	Identifier(s): 1110722, 1110733, 1179716
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 3110988, 34009, 61826, 62928, 65163, 65795
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 005303, 184432, 435594
Country: FR	Base de données publique des médicaments	Identifier(s): 68232350, 68354386
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139961, 139963, 147367, 21567, 36406, 373755, 373757, 48207, 81566
Country: HK	Department of Health Drug Office	Identifier(s): 43324
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-271461417, HR-H-878091382
Country: IE	Health Products Regulatory Authority	Identifier(s): 57916, 57947, 57974, 58020, 58026
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3617
Country: IT	Agenzia del Farmaco	Identifier(s): 033345012, 033345149
Country: JP	医薬品医療機器総合機構	Identifier(s): 2160004F1027, 2160004F2023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003212, 1086335, 1088487, 1093339
Country: MT	Medicines Authority	Identifier(s): AA227/00703, AA908/20401
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 356M2000, 612M97
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 47651, 55727
Country: SG	Health Sciences Authority	Identifier(s): 11816P
Country: US	FDA, National Drug Code	Identifier(s): 64896-671, 64896-672, 64896-681, 64896-682, 64896-691, 64896-692
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/7.3/0479, 34/7.3/0107, 36/7.3/0133